CytRx to receive up to $40 mln from Hercules Technology
CytRx Corp entered into a long-term loan and security agreement with Hercules Technology Growth Capital Inc and Hercules Technology III LP for up to $40 million in financing. CytRx is a biopharmaceutical research and development company specializing in oncology.
9 February 2016•4 mins read
